Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
Monica Marzagalli, Marina Montagnani Marelli, Lavinia Casati, et al.
Frontiers in Endocrinology (2016) Vol. 7
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
Tamás Deli, Mónika Orosz, Attila Jakab
Pathology & Oncology Research (2019) Vol. 26, Iss. 1, pp. 63-78
Open Access | Times Cited: 152
Role of estrogen receptors in health and disease
Peng Chen, Bo Li, Ling Ouyang
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 137
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Christopher P. Vellano, Michael G. White, Miles C. Andrews, et al.
Nature (2022) Vol. 606, Iss. 7915, pp. 797-803
Open Access | Times Cited: 95
Sex and Gender Disparities in Melanoma
Maria Bellenghi, Rossella Puglisi, Giada Pontecorvi, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1819-1819
Open Access | Times Cited: 110
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis
Linjie Zhao, Shuang Huang, Shenglin Mei, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 16
Open Access | Times Cited: 64
Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
Se Ryeong Jang, Nikita Nikita, Joshua Banks, et al.
JAMA Network Open (2021) Vol. 4, Iss. 12, pp. e2136823-e2136823
Open Access | Times Cited: 46
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma
Binita Chakraborty, Jovita Byemerwa, Jonathan H. Shepherd, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 23
Open Access | Times Cited: 45
Estrogen Receptors and Melanoma: A Review
Emi Dika, Annalisa Patrizi, Martina Lambertini, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1463-1463
Open Access | Times Cited: 54
Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date
Amélie Boespflug, Julie Caramel, Stéphane Dalle, et al.
Therapeutic Advances in Medical Oncology (2017) Vol. 9, Iss. 7, pp. 481-492
Open Access | Times Cited: 50
Gender Differences and Outcomes in Melanoma Patients
Francesca Morgese, Caterina Sampaolesi, Mariangela Torniai, et al.
Oncology and Therapy (2020) Vol. 8, Iss. 1, pp. 103-114
Open Access | Times Cited: 48
Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Edoardo Botteri, Nathalie C. Støer, Solveig Sakshaug, et al.
International Journal of Cancer (2017) Vol. 141, Iss. 9, pp. 1763-1770
Open Access | Times Cited: 46
Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers
David J. Duffy, Christine E. Schnitzler, Lorraine Karpinski, et al.
Communications Biology (2018) Vol. 1, Iss. 1
Open Access | Times Cited: 43
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
Alejandro García‐Álvarez, Carolina Ortiz, Eva Muñoz‐Couselo
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 3709-3719
Open Access | Times Cited: 31
Unraveling the controversy: exploring the link between sex hormones and skin cancers through a meta-analysis and systematic review
Tian Zhao, Chenyu Li, Ai Zhong, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Antitumor Effects of Quercetin and Luteolin in A375 Cutaneous Melanoma Cell Line Are Mediated by Upregulation of P-ERK, c-Myc, and the Upstream GPER
S. A. Hussein, Nidaa A. Ababneh, Noor Tarawneh, et al.
Life (2025) Vol. 15, Iss. 3, pp. 417-417
Open Access
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway
Fan Xue, Luming Wu, Tong Cheng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort
Tina J. Hieken, Amy E. Glasgow, Elizabeth Ann L. Enninga, et al.
Journal of Women s Health (2020) Vol. 29, Iss. 9, pp. 1160-1167
Open Access | Times Cited: 32
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments
Ida Taglialatela, Alice Indini, Giulia Santanelli, et al.
Tumori Journal (2024)
Closed Access | Times Cited: 3
Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score
Yanhong Shou, Lu Yang, Yongsheng Yang, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 25
Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside
Swaathi Jayaraman, Joel M. Reid, John R. Hawse, et al.
Endocrinology (2021) Vol. 162, Iss. 12
Open Access | Times Cited: 22
The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy
Paola Matarrese, Gianfranco Mattia, Maria Pagano, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3287-3287
Open Access | Times Cited: 21
Hepatocyte‐generated 27‐hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha
Wei Tian, Wenxiao Pang, Yao Ge, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 3, pp. 2929-2938
Closed Access | Times Cited: 26
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication
Atieh Hajirahimkhan, Obinna Mbachu, Charlotte Simmler, et al.
Journal of Natural Products (2018) Vol. 81, Iss. 4, pp. 966-975
Open Access | Times Cited: 24
Ca2+ as a therapeutic target in cancer
Scott Gross, Pranava Mallu, Hinal Joshi, et al.
Advances in cancer research (2020), pp. 233-317
Open Access | Times Cited: 23
Expression of G protein‐coupled oestrogen receptor in melanoma and in pregnancy‐associated melanoma
Melinda Fábián, Fanni Rencz, Tibor Krenács, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 9, pp. 1453-1461
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top